A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients
The goal of the study is to explore the efficacy and safety of hyperbaric oxygen in the neoadjuvant treatment of breast cancer patients
Trial Details
- NCT ID
- NCT06811870
- Phase
- PHASE1 / PHASE2
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- RECRUITING
- Cancer Type
- Breast Cancer
- Interventions
- hyperbaric oxygen treatment
- Locations (sample)
- Guangzhou, Guangdong, China|23.11667,113.25
- Shantou, Guangdong, China|23.35489,116.67876
Key Eligibility Criteria
- Understand the study process, participate in the study voluntarily, and sign the informed consent form.
- patients with histopathologically confirmed initial unilateral primary invasive breast cancer, occult breast cancer, Patients with histopathologica…
- aged ≥ 18 years and ≤ 60 years, female
- patients who meet the inclusion criteria for neoadjuvant therapy to receive neoadjuvant therapy for breast cancer (locally advanced) Patients with …
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Breast Cancer Trials on Trialify →